Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Total Liabilities (2023 - 2026)

BioAge Labs' Total Liabilities history spans 3 years, with the latest figure at $22.8 million for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 34.95% to $22.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.8 million, a 34.95% decrease, with the full-year FY2025 number at $22.8 million, down 34.95% from a year prior.
  • Total Liabilities hit $22.8 million in Q4 2025 for BioAge Labs, down from $27.6 million in the prior quarter.
  • Over the last five years, Total Liabilities for BIOA hit a ceiling of $197.1 million in Q2 2024 and a floor of $22.8 million in Q4 2025.
  • Historically, Total Liabilities has averaged $68.5 million across 3 years, with a median of $30.7 million in 2025.
  • The widest YoY moves for Total Liabilities: up 16.9% in 2025, down 86.12% in 2025.
  • Tracing BIOA's Total Liabilities over 3 years: stood at $66.6 million in 2023, then plummeted by 47.29% to $35.1 million in 2024, then crashed by 34.95% to $22.8 million in 2025.
  • Business Quant data shows Total Liabilities for BIOA at $22.8 million in Q4 2025, $27.6 million in Q3 2025, and $27.4 million in Q2 2025.